{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:09:07Z","timestamp":1776938947797,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T00:00:00Z","timestamp":1179705600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/nm1588","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T01:21:08Z","timestamp":1179796868000},"page":"736-741","source":"Crossref","is-referenced-by-count":127,"title":["Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"13","author":[{"given":"Hind","family":"Medyouf","sequence":"first","affiliation":[]},{"given":"H\u00e9l\u00e8ne","family":"Alcalde","sequence":"additional","affiliation":[]},{"given":"Caroline","family":"Berthier","sequence":"additional","affiliation":[]},{"given":"Marie Claude","family":"Guillemin","sequence":"additional","affiliation":[]},{"given":"Nuno R","family":"dos Santos","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Janin","sequence":"additional","affiliation":[]},{"given":"Didier","family":"Decaudin","sequence":"additional","affiliation":[]},{"given":"Hugues","family":"de Th\u00e9","sequence":"additional","affiliation":[]},{"given":"Jacques","family":"Ghysdael","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,5,21]]},"reference":[{"key":"BFnm1588_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1074-7613(04)00052-4","volume":"20","author":"JR Neilson","year":"2004","unstructured":"Neilson, J.R., Winslow, M.M., Hur, E.M. & Crabtree, G.R. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity 20, 255\u2013266 (2004).","journal-title":"Immunity"},{"key":"BFnm1588_CR2","doi-asserted-by":"publisher","first-page":"9398","DOI":"10.1073\/pnas.152665399","volume":"99","author":"OF Bueno","year":"2002","unstructured":"Bueno, O.F., Brandt, E.B., Rothenberg, M.E. & Molkentin, J.D. Defective T cell development and function in calcineurin A \u03b2-deficient mice. Proc. Natl. Acad. Sci. USA 99, 9398\u20139403 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1588_CR3","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"WS Pear","year":"1996","unstructured":"Pear, W.S. et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283\u20132291 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm1588_CR4","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1182\/blood.V95.12.3891","volume":"95","author":"C Carron","year":"2000","unstructured":"Carron, C. et al. TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 95, 3891\u20133899 (2000).","journal-title":"Blood"},{"key":"BFnm1588_CR5","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1128\/MCB.20.20.7505-7515.2000","volume":"20","author":"JC Aster","year":"2000","unstructured":"Aster, J.C. et al. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol. Cell. Biol. 20, 7505\u20137515 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1588_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","volume":"278","author":"V Lacronique","year":"1997","unstructured":"Lacronique, V. et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309\u20131312 (1997).","journal-title":"Science"},{"key":"BFnm1588_CR7","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","volume":"101","author":"M Benekli","year":"2003","unstructured":"Benekli, M., Baer, M.R., Baumann, H. & Wetzler, M. Signal transducer and activator of transcription proteins in leukemias. Blood 101, 2940\u20132954 (2003).","journal-title":"Blood"},{"key":"BFnm1588_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng, A.P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269\u2013271 (2004).","journal-title":"Science"},{"key":"BFnm1588_CR9","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1101\/gad.1102703","volume":"17","author":"PG Hogan","year":"2003","unstructured":"Hogan, P.G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205\u20132232 (2003).","journal-title":"Genes Dev."},{"issue":"Suppl","key":"BFnm1588_CR10","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","volume":"109","author":"GR Crabtree","year":"2002","unstructured":"Crabtree, G.R. & Olson, E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 Suppl,, S67\u2013S79 (2002).","journal-title":"Cell"},{"key":"BFnm1588_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","volume":"5","author":"F Macian","year":"2005","unstructured":"Macian, F. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472\u2013484 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm1588_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1128\/MCB.26.1.209-220.2006","volume":"26","author":"A Dumortier","year":"2006","unstructured":"Dumortier, A. et al. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol. Cell. Biol. 26, 209\u2013220 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1588_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/sj.onc.1203321","volume":"19","author":"K Blyth","year":"2000","unstructured":"Blyth, K. et al. Sensitivity to myc-induced apoptosis is retained in spontaneous and transplanted lymphomas of CD2-mycER mice. Oncogene 19, 773\u2013782 (2000).","journal-title":"Oncogene"},{"key":"BFnm1588_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.cad.0000215061.78189.4e","volume":"17","author":"D Decaudin","year":"2006","unstructured":"Decaudin, D. et al. High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice. Anticancer Drugs 17, 685\u2013695 (2006).","journal-title":"Anticancer Drugs"},{"key":"BFnm1588_CR15","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1182\/blood-2006-09-048801","volume":"109","author":"NR Dos Santos","year":"2007","unstructured":"Dos Santos, N.R. et al. Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia. Blood 109, 3972\u20133981 (2007).","journal-title":"Blood"},{"key":"BFnm1588_CR16","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0006-291X(03)01537-7","volume":"311","author":"H Ke","year":"2003","unstructured":"Ke, H. & Huai, Q. Structures of calcineurin and its complexes with immunophilins-immunosuppressants. Biochem. Biophys. Res. Commun. 311, 1095\u20131102 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm1588_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/357692a0","volume":"357","author":"SJ O'Keefe","year":"1992","unstructured":"O'Keefe, S.J., Tamura, J., Kincaid, R.L., Tocci, M.J. & O'Neill, E.A. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 357, 692\u2013694 (1992).","journal-title":"Nature"},{"key":"BFnm1588_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1084\/jem.191.1.9","volume":"191","author":"AM Ranger","year":"2000","unstructured":"Ranger, A.M. et al. The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J. Exp. Med. 191, 9\u201322 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnm1588_CR19","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1182\/blood-2005-02-0493","volume":"106","author":"SZ Glud","year":"2005","unstructured":"Glud, S.Z. et al. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 106, 3546\u20133552 (2005).","journal-title":"Blood"},{"key":"BFnm1588_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/ncb816","volume":"4","author":"S Jauliac","year":"2002","unstructured":"Jauliac, S. et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat. Cell Biol. 4, 540\u2013544 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFnm1588_CR21","doi-asserted-by":"publisher","first-page":"17246","DOI":"10.1074\/jbc.M300528200","volume":"278","author":"JW Neal","year":"2003","unstructured":"Neal, J.W. & Clipstone, N.A. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3\u2013L1 fibroblasts. J. Biol. Chem. 278, 17246\u201317254 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm1588_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2141.2004.05313.x","volume":"128","author":"T Marafioti","year":"2005","unstructured":"Marafioti, T. et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br. J. Haematol. 128, 333\u2013342 (2005).","journal-title":"Br. J. Haematol."},{"key":"BFnm1588_CR23","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2005-03-1167","volume":"106","author":"LV Pham","year":"2005","unstructured":"Pham, L.V., Tamayo, A.T., Yoshimura, L.C., Lin-Lee, Y.C. & Ford, R.J. Constitutive NF-\u03baB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106, 3940\u20133947 (2005).","journal-title":"Blood"},{"key":"BFnm1588_CR24","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1038\/sj.emboj.7601246","volume":"25","author":"M Buchholz","year":"2006","unstructured":"Buchholz, M. et al. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+\/calcineurin signaling pathway. EMBO J. 25, 3714\u20133724 (2006).","journal-title":"EMBO J."},{"key":"BFnm1588_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa035091","volume":"349","author":"CH Pui","year":"2003","unstructured":"Pui, C.H. et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N. Engl. J. Med. 349, 640\u2013649 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1588_CR26","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/blood-2005-02-0687","volume":"106","author":"JS Abramson","year":"2005","unstructured":"Abramson, J.S. & Shipp, M.A. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 106, 1164\u20131174 (2005).","journal-title":"Blood"},{"key":"BFnm1588_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita, S., Kojima, T. & Kitamura, T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7, 1063\u20131066 (2000).","journal-title":"Gene Ther."},{"key":"BFnm1588_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493\u2013501 (1992).","journal-title":"J. Cell Biol."},{"key":"BFnm1588_CR29","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/labinvest.3700145","volume":"84","author":"WL Zhao","year":"2004","unstructured":"Zhao, W.L. et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab. Invest. 84, 1512\u20131519 (2004).","journal-title":"Lab. Invest."},{"key":"BFnm1588_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1074-7613(00)80026-6","volume":"10","author":"S Chuvpilo","year":"1999","unstructured":"Chuvpilo, S. et al. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10, 261\u2013269 (1999).","journal-title":"Immunity"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1588","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:29:03Z","timestamp":1684448943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,21]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BFnm1588"],"URL":"https:\/\/doi.org\/10.1038\/nm1588","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,21]]}}}